Qinghai Spring(600381)
Search documents
食品加工板块10月23日涨0.05%,*ST春天领涨,主力资金净流出9880.5万元
Zheng Xing Xing Ye Ri Bao· 2025-10-23 08:20
Market Overview - On October 23, the food processing sector rose by 0.05% compared to the previous trading day, with *ST Chuntian leading the gains [1] - The Shanghai Composite Index closed at 3922.41, up 0.22%, while the Shenzhen Component Index closed at 13025.45, also up 0.22% [1] Stock Performance - The following stocks in the food processing sector showed notable performance: - *ST Chuntian (600381) closed at 5.58, up 2.39% with a trading volume of 146,300 shares and a turnover of 80.837 million yuan [1] - Huifa Food (603536) closed at 11.14, up 1.74% with a trading volume of 104,700 shares and a turnover of 116 million yuan [1] - Kemei Food (002661) closed at 9.68, up 1.36% with a trading volume of 33,000 shares and a turnover of 31.6787 million yuan [1] - Other notable stocks include Jiyuan Group (603262), Weizhi Xiang (605089), and Xiwang Food (000639) with respective gains [1] Capital Flow - The food processing sector experienced a net outflow of 98.805 million yuan from institutional investors, while retail investors saw a net inflow of 105 million yuan [2] - The following stocks had significant capital flow: - Xiwang Food (000639) had a net inflow of 19.6873 million yuan from institutional investors, but a net outflow from retail investors [3] - Jiyuan Group (603262) also saw a net inflow from institutional investors, while retail investors had a slight outflow [3] - Other stocks like Jinzi Ham (002515) and Sanyuan Food (002216) showed mixed capital flows [3]
*ST春天(600381) - 青海春天关于股票交易风险提示的公告
2025-10-22 10:17
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 青海春天药用资源科技股份有限公司(以下简称"公司")股价剔除大盘整体因素 后的实际波动幅度较大,公司特别提醒广大投资者注意二级市场交易风险,相关提示 如下: 股票代码:600381 股票简称:*ST 春天 公告编号:2025-048 青海春天药用资源科技股份有限公司 关于股票交易风险提示的公告 二、生产经营风险 公司于 2025 年 10 月 21 日披露了《2025 年第三季度报告》,2025 年第三季度营业 收入为 21,253.03 万元、利润总额为 374.34 万元、归属于上市公司股东的净利润为 -283.17 万元、归属于上市公司股东扣除非经常性损益后的净利润为-589.04 万元。公 司业绩连续亏损,目前,生产经营情况正常,不存在影响公司股票交易价格大幅波动 的重大事项,敬请广大投资者注意投资风险。 三、控股股东质押风险 公司控股股东西藏荣恩科技有限公司累计质押 11,362 万股,占其持股总数的 60.24%,占公司总股本的 19.35%。控股股东及其一致行动人合 ...
食品加工板块10月22日涨0.04%,*ST春天领涨,主力资金净流出8735.75万元
Zheng Xing Xing Ye Ri Bao· 2025-10-22 08:19
Core Insights - The food processing sector experienced a slight increase of 0.04% on October 22, with *ST Chuntian leading the gains [1] - The Shanghai Composite Index closed at 3913.76, down 0.07%, while the Shenzhen Component Index closed at 12996.61, down 0.62% [1] Stock Performance - *ST Chuntian (600381) closed at 5.45, up 5.01% with a trading volume of 97,100 shares and a turnover of 52.64 million yuan [1] - Other notable gainers included Jinzi Ham (002515) up 1.91%, Xiwang Food (000639) up 1.27%, and Delisi (002330) up 1.23% [1] - Conversely, Baba Food (605338) saw a decline of 2.72%, while Jiaoda Onl (600530) fell by 2.41% [2] Capital Flow - The food processing sector saw a net outflow of 87.36 million yuan from institutional investors, while retail investors contributed a net inflow of 124 million yuan [2] - The main stocks with significant capital flow included *ST Chuntian, which had a net inflow of 14.16 million yuan from institutional investors [3] - Other stocks like Guangming Meat (600073) and Jindawei (002626) also experienced varying degrees of net inflow and outflow from different investor categories [3]
*ST春天(600381.SH):2025年三季报净利润为-283.17万元
Sou Hu Cai Jing· 2025-10-20 22:17
Core Insights - *ST Chuntian reported a total operating revenue of 213 million yuan as of September 30, 2025 [1] - The company recorded a net profit attributable to shareholders of -2.83 million yuan as of September 30, 2025 [1] - Operating cash flow showed a net outflow of 68.92 million yuan, a decrease of 88.37 million yuan compared to the same period last year, representing a year-on-year decline of 454.20% [1] Financial Ratios - The latest debt-to-asset ratio for *ST Chuntian is 4.20% as of September 30, 2025 [3] - The gross profit margin is 47.52%, which is a decrease of 13.89 percentage points from the previous quarter [4] - The return on equity (ROE) stands at -0.28% as of September 30, 2025 [4] - The diluted earnings per share (EPS) is -0.01 yuan [4] - The total asset turnover ratio is 0.19 times [4] - The inventory turnover ratio is 0.68 times [4] Shareholder Information - The number of shareholders is 26,500, with the top ten shareholders holding a total of 295 million shares, accounting for 50.24% of the total share capital [4] - The largest shareholder is Tibet Rong'en Technology Co., Ltd., holding 32.1% of the shares [4]
青海春天药用资源科技股份有限公司 2025年第三季度报告
Shang Hai Zheng Quan Bao· 2025-10-20 19:00
Core Viewpoint - The company, Qinghai Spring Medicine Resources Technology Co., Ltd., has announced the continuation of its accounting firm for the 2025 fiscal year and the cancellation of its supervisory board, with the audit committee taking over its responsibilities [9][71]. Financial Data - The company reported a total operating income of 212.53 million yuan and a net profit attributable to shareholders of -28.32 million yuan for the first three quarters of 2025 [45][46]. - The company has experienced continuous losses, with a net profit after deducting non-recurring gains and losses of -58.90 million yuan [45][46]. Shareholder Information - The company plans to hold its second extraordinary general meeting of 2025 on November 5, 2025, to discuss various proposals, including the appointment of the accounting firm and the cancellation of the supervisory board [58][59]. Audit Firm Appointment - The company has proposed to reappoint Zhengdan Zhiyuan (Shenzhen) Accounting Firm for the 2025 financial audit and internal control audit, with fees set at 800,000 yuan for the financial audit and 300,000 yuan for the internal control audit, totaling 1.1 million yuan, which is the same as the previous year [9][16][28]. Corporate Governance Changes - The company has decided to abolish its supervisory board, transferring its responsibilities to the audit committee, in line with updated regulations and to enhance corporate governance [71][72].
*ST春天发布前三季度业绩,归母净亏损283.17万元
智通财经网· 2025-10-20 10:06
Core Viewpoint - *ST Chuntian (600381.SH) reported a revenue of 213 million yuan for the first three quarters of 2025, reflecting a year-on-year growth of 7.32% [1] Financial Performance - The net loss attributable to shareholders of the listed company was 2.8317 million yuan [1] - The net loss attributable to shareholders, excluding non-recurring gains and losses, was 5.8904 million yuan [1] - The basic loss per share was 0.005 yuan [1]
*ST春天(600381.SH)发布前三季度业绩,归母净亏损283.17万元

智通财经网· 2025-10-20 10:02
Core Viewpoint - *ST Chuntian (600381.SH) reported a revenue of 213 million yuan for the first three quarters of 2025, reflecting a year-on-year growth of 7.32% [1] Financial Performance - The net loss attributable to shareholders of the listed company was 2.83 million yuan [1] - The net loss attributable to shareholders, excluding non-recurring gains and losses, was 5.89 million yuan [1] - The basic loss per share was 0.005 yuan [1]
*ST春天(600381) - 青海春天关于股票交易异常波动的公告
2025-10-20 10:01
股票代码:600381 股票简称:*ST 春天 公告编号:2025-047 青海春天药用资源科技股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 青海春天药用资源科技股份有限公司(以下简称"公司")股票交易在 2025 年 10 月 16 日、10 月 17 日、10 月 20 日连续 3 个交易日内日收盘价格涨幅偏离值累计达 到 12%,属于股票交易异常波动。 经公司自查及向公司控股股东、实际控制人发函核实、确认,截至本公告披露 日,除公司已披露事项外,不存在其它应披露而未披露的重大事项。 公司向控股股东及实际控制人发出问询函件,公司控股股东及实际控制人回函确认 公司控股股东质押比例较高。公司控股股东西藏荣恩科技有限公司累计质押 11,362 万股,占其持股总数的 60.24%,占公司总股本的 19.35%。控股股东及其一致行 动人合计质押 14,376 万股,占其持股总数的 58.59%,占公司总股本的 24.49%。 公司业绩连续亏损。公司 2025 年前三季度营业收入为 ...
*ST春天(600381) - 青海春天董事会议事规则(草案)
2025-10-20 10:00
青海春天药用资源科技股份有限公司董事会议事规则 青海春天药用资源科技股份有限公司 董事会议事规则 (2025 年 10 月修订) 第一章 总 则 第一条 为进一步规范青海春天药用资源科技股份有限公司(以下简称"公 司")董事会的议事方式和决策程序,促使董事和董事会有效地履行其职责,提 高董事会规范运作和科学决策水平,根据我国《公司法》《证券法》、中国证券监 督管理委员会(以下简称中国证监会)《上市公司治理准则》、上海证券交易所(以 下简称上交所)《股票上市规则》、《上市公司自律监管指引第 1 号-规范运作》及 公司《章程》等有关规定,制订本规则。 第一章 董事会的组成 第二条 公司董事会是公司经营管理的决策机构,在公司《章程》和股东会 的授权范围内负责公司发展目标和重大经营活动的决策。 第三条 董事会由七名董事组成,其中董事四名,独立董事三名(其中至少 一名为会计专业人士)。董事会设董事长一人,由全体董事的过半数选举产生, 是公司法定代表人。 (二)执行股东会的决议; 1 青海春天药用资源科技股份有限公司董事会议事规则 (三)决定公司的经营计划和投资方案; (四)制订公司的利润分配方案和弥补亏损方案; (五) ...
*ST春天(600381) - 青海春天董事会战略委员会工作规则
2025-10-20 10:00
青海春天药用资源科技股份有限公司董事会战略委员会工作规则 青海春天药用资源科技股份有限公司 第一章 总则 第一条 青海春天药用资源科技股份有限公司(以下简称"公司")为完善 公司治理结构,加强决策科学性,根据我国《公司法》《证券法》《上海证券交 易所股票上市规则》《上海证券交易所上市公司自律监管指引第1号—规范运作》 等法律法规、规范性文件和公司《章程》的有关规定和要求,制定本《规则》。 董事会战略发展委员会工作规则 (2025年10月修订) 第二条 董事会战略发展委员会(以下简称"委员会")是董事会下设的专 门委员会,主要负责对公司长期发展战略和重大投资决策进行研究并提出建议。 第二章 人员组成 第三条 委员会由三名公司董事组成,其中应至少包括独立董事一名。 第四条 委员会委员由董事长、二分之一以上独立董事或者全体董事的三分 之一提名,并由董事会选举产生。 第五条 委员会设主任委员(召集人)一名,负责主持委员会工作,由董事 长担任。 第六条 委员会任期与董事任期一致,委员任期届满,连选可以连任。期间 如有委员不再担任董事职务,自动失去委员资格,并由委员会根据上述第三至第 五条规定补足委员人数。 第三章 职责 ...